Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001645627-18-000079)

Filing Details

Accession Number:: 0001645627-18-000079
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-14 17:04:27
Reporting Period:: 2018-12-11

Accepted Time:: 2018-12-14 17:04:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1528172	Endonovo Therapeutics Inc.	ENDV	Pharmaceutical Preparations (2834)	452552528

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1645627	Scott Michael Mann	6320 Canoga Avenue Woodland Hills CA 91367	President	No	Yes	No	No

Transaction Summary

Purchased:	17,000 shares	Avg. Price: $0.02	Total Value: $375.40
Number of Shares After Transactions:	26,358,898 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-11	2,000	$0.02	26,343,898	No	4	P	Direct
Common Stock	Acquisiton	2018-12-11	2,000	$0.02	26,345,898	No	4	P	Direct
Common Stock	Acquisiton	2018-12-11	2,000	$0.02	26,347,898	No	4	P	Direct
Common Stock	Acquisiton	2018-12-12	2,000	$0.02	26,349,898	No	4	P	Direct
Common Stock	Acquisiton	2018-12-12	2,000	$0.02	26,351,898	No	4	P	Direct
Common Stock	Acquisiton	2018-12-12	2,000	$0.02	26,353,898	No	4	P	Direct
Common Stock	Acquisiton	2018-12-12	1,000	$0.02	26,354,898	No	4	P	Direct
Common Stock	Acquisiton	2018-12-12	2,000	$0.02	26,356,898	No	4	P	Direct
Common Stock	Acquisiton	2018-12-12	1,000	$0.02	26,357,898	No	4	P	Direct
Common Stock	Acquisiton	2018-12-13	1,000	$0.02	26,358,898	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct